hims hers wegovy - Search News

News

Hims, Novo Nordisk and Hers stock

Insider on MSN · 1h

Hims & Hers stock plunges after Novo Nordisk ends its brief partnership

The Danish pharmaceutical said it was ending the partnership because Hims is selling and promoting a cheaper copycat of its blockbuster drug Wegovy.

The Wall Street Journal on MSN · 3h

Hims & Hers Stock Drops More Than 30% After Novo Nordisk Breakup

The Danish maker of obesity drugs abruptly ended a Wegovy distribution deal with the telehealth firm, citing allegations about Hims’ compounding and deceptive marketing practices.

Financial Times · 10h

Novo Nordisk ends Hims & Hers tie-up over copycat Wegovy drugs

Shares in two companies slide as Danish drugmaker accuses US telehealth group of deceptively marketing replica treatments

4hon MSN

Hims & Hers’ stock plunges. Here’s why Wegovy parent ended its partnership with the company.

Hims & Hers Health’s stock booked record losses Monday after Novo Nordisk, maker of the weight-loss drug Wegovy, said it was ...

9hon MSN

Why Hims & Hers Health Stock Is Crashing Today

The loss of its ability to sell Wegovy is a significant hit to Hims & Hers' business. The massive drop today in its stock ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results